Main Capital goes for majority stake in Cisbox

Keensight’s Biovian, 3P join to form biologics CDMO.

2 February 2024•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.